Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients

Clinical trial NCT03760822 · UNKNOWN

Trial details

NCT number: NCT03760822
Sponsor: Federation Francophone de Cancerologie Digestive
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stomach Cancer Stomach Neoplasm Gastric Cancer Gastroesophageal Junction Adenocarcinoma

Start date: 2018-11-16
Primary completion: 2024-12-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.